- Research article
- Open Access
Study of the betulin enriched birch bark extracts effects on human carcinoma cells and ear inflammation
Chemistry Central Journal volume 6, Article number: 137 (2012)
Pentacyclic triterpenes, mainly betulin and betulinic acid, are valuable anticancer agents found in the bark of birch tree. This study evaluates birch bark extracts for the active principles composition.
New improved extraction methods were applied on the bark of Betula pendula in order to reach the maximum content in active principles. Extracts were analyzed by HPLC-MS, Raman, SERS and 13C NMR spectroscopy which revealed a very high yield of betulin (over 90%). Growth inhibiting effects were measured in vitro on four malignant human cell lines: A431 (skin epidermoid carcinoma), A2780 (ovarian carcinoma), HeLa (cervix adenocarcinoma) and MCF7 (breast adenocarcinoma), by means of MTT assay. All of the prepared bark extracts exerted a pronounced antiproliferative effect against human cancer cell lines. In vivo studies involved the anti-inflammatory effect of birch extracts on TPA-induced model of inflammation in mice.
The research revealed the efficacy of the extraction procedures as well as the antiproliferative and anti-inflammatory effects of birch extracts.
Pentacyclic triterpenes are a class of compounds extensively studied as future anticancer agents. One of the most studied substances within this class is betulinic acid (BA) whose antineoplasic effectiveness is diminished by its poor water solubility . That is why a lot of efforts have been put in surpassing this disadvantage by either obtaining complexes with hydrophilic substances such as cyclodextrins  or by derivatising BA to more soluble compounds .
Betulinic acid (Figure 1a) can be found in many plants, especially Betula sp.; also, it can be obtained by chemical synthesis from its precursor, betulin (Figure 1b), which is present in the same specie . The percentage of active substances in the birch bark differs from one species to another; few studies have been made on Betula pendula Roth which can be found in Romania, regarding the content in betulin/betulinic acid in its outer bark.
Birch tree has been known for a long time for its healing properties; birch bark oil was used in folk medicine for the treatment of skin diseases (eczema, psoriasis) . It is known that Native Americans used the bark to prepare teas for the treatment of digestive tract infections , so it is expected that the use of the above mentioned species as raw material for the extraction of active principles could be an important source of compounds for the treatment of various pathologies. In vitro and in vivo studies have revealed the interferon-inducing activity of both dry birch bark extract and betulin . Betulin has three active positions in its structure, secondary hydroxyl group at C-3, primary hydroxyl group at C-28 and a double C-C bonding at C-20, where chemical modulations can be performed in order to obtain different types of derivatives . By oxidation of the C-28 hydroxylic group to carboxyl, betulin can be rapidly converted to its more active derivate, betulinic acid, with a wide spectrum of biological and pharmacological activities such as: anti-inflammatory, antimalarial, anti-HIV, antineoplasic [8, 9].
Recent studies have shown the possibility of obtaining an extract from the birch tree outer bark with over 70% betulin . Our present work combines solvent extraction with a heating procedure in order to prepare a precipitate, based on the betulin’s sublimation property . This combination of procedures led to a content of over 90% betulin in the dry extract.
Results and discussion
The present report continues the work previously presented  by our team, falling in a project which focuses on finding new antitumor natural sources like birch bark; in the same time our present report brings important new research data. We improved in a unique manner the extraction procedure of betulin and betulinic acid from birch bark, by obtaining a higher amount of active compound (over 90%) than previous studies. Also, we enriched the knowledge on birch bark extract regarding its antitumor properties by analyzing its activity on a new cell line (A2780). All the elements are new and represent a step forward in the preclinical evaluation of these important antitumor compounds.
In the present HPLC/MS analysis the expected ion, according to betulin molecular weight (M = 442.3), would be its proton aduct, at m/z 443.3. Against expectations, this ion has not been noticed, but a majority ion was spotted at m/z 425.3, corresponding to the aduct formed with the proton by the dehydrated betulin molecule. Basically, betulin molecule dehydrates at the drying temperature of mobile phase inside the chromatograph (400°C) or during arc ionisation followed by protonation. Retention times were 2.75 min for betulin and 3 min for betulinic acid (Additional file 1: Figure S1).
HPLC technique has been previously used for the quantification of pentacyclic triterpenes in natural extracts . In our previous study  application of HPLC/MS analysis revealed 57% percentage of betulin and 3% betulinic acid in the birch bark of Betula pendula Roth.
Isolation of triterpenes was reported from birch species; birch bark revealed the presence of triterpene derivates of lupane skeleton, like betulin and betulinic acid . Betulin is an abundant natural triterpene, its presence in natural sources making the extraction procedure very important for large scale production. Extraction procedures are very different, from ultrasonic-assisted extraction  to supercritical carbon dioxide extraction .
The percentage of the active components in the birch bark differs from one specie to another; Diouf et al.  reported in 2009 a 56% betulin in the bark of yellow birch (Betula alleghaniensis Britton) in Quebec, Canada. A 34% content in betulin was reported by Jäger et al. in 2008 . However, few studies have been made on the specie, Betula pendula Roth, in terms of the content of betulin/betulinic acid in the outer bark. Extraction of betulin can be conducted using high boiling point hydrocarbon solvents or water azeotrops of alcohols .
In a previous study  we used a mixture of solvents and continuous Soxhlet extraction for betulin preparation, reaching a percentage of over 50% active compound. In the present article we used two organic solvents, ethanol and propanol, with much improved results, up to 97% (see Table 1). This high amount of betulin makes this birch species very suitable for industrial preparation of betulin and its derivatives.
13C-NMR spectroscopy is a highly sensitive technique that has been used for betulin characterization. Solid state 13C-NMR spectra were recorded for all prepared sample. From the integrated analysis of the betulin peaks and of the compound resonances in the region of 10–110 ppm we can conclude that the presence of betulin in the extracts is significantly higher compared to the previously reported products . The presence of betulinic acid could not be determined from this experiment, which leads us to the conclusion that the amount of betulinic acid in the extract is smaller than 5%. Moreover, the samples 1 pp and 3 pp (Additional file 2: Figure S2) are characterized by a high degree of crystallinity revealed by the shapes of the solid-state NMR resonances.
Raman spectroscopy could provide semi-quantitative information concerning the triterpene content in the final extracts by analyzing the relative intensity ratio of the 1642 cm-1 (triterpene C = C mode) and 1601 cm-1 band, assigned to other organic residual compounds from the bark. Upon betulin vibrational characterization , we demonstrated the possibility to apply Raman spectroscopy for the prediction of the highest triterpene content in bark species, for selecting the appropriate harvesting period or for the direct selection in the field of individual genotypes using appropriate portable Raman equipment.
The relative intensity ratio of the band at 1642 cm-1 representative for the triterpenes and the band at 1606 cm-1 assigned to other species than triterpenes, I1642 / I1606 varied from 0.9 to 1.1 in nine samples of birch bark used for extraction protocol. The present ratio intensity of these bands for the 1 pp and 3 pp is 5.8 and 6.1 respectively (Additional file 3: Figure S3), showing a higher purity compared to the previously reported extracts .
SERS signal of the extract presents large differences in band positions and relative intensity, compared to the corresponding Raman spectrum of the solid extract, confirming the chemisorption of the main specie with respect to the Ag nanoparticles surface. The most enhanced bands were observed in the 1400–1200 cm-1 spectral range, where the stretching modes of the skeletal vibrational structure are assigned . The vibrational mode at 1642 cm-1 is less enhanced, indicating that the terminal functional group –CH2OH of betulin is less involved in the chemisorption on the Ag nanoparticles surface and the betulin structure adopted a more tilted orientation with respect to the Ag nanoparticles. This supposition is confirmed by the broadening of the SERS bands compared to the Raman ones (Additional file 4: Figure S4).
Raman spectroscopy showed that the extracts could be sensitively characterised, allowing to highlight the high betulin content in the solid extracts. SERS spectra revealed a very good reproducibility and stability in time even after 48 hours from sample preparation and also the availability to adsorption on the nanoparticles surface, thus the possibility to detect trace amounts of active compound in aqueous media. Concluding, SERS technique allowed detecting the adsorbed species from natural extract at very low concentrations, compatible with the physiological values. To the best of our knowledge, this is the first SERS report of adsorbed betulin from natural extracts.
All of the prepared bark extracts exerted a pronounced antiproliferative effect against human cancer cell lines. The currently used four cell lines exhibited similar sensitivities for the extracts and no substantial differences were detected between proliferation inhibitory potencies of the tested samples (Figure 2).
The goal of the MTT assay was a direct comparison of the extracts, concluding that the IC50 values of all the samples are between 1 and 5 μg/ml. Therefore, the substantial differences in betulin and betulinic acid content of the extracts are not reflected in the antiproliferative activities. The reason of this contradiction is out of the scope of the present work, but the presence of other active natural compounds in birch bark, including flavonoids, seems like an obvious explanation .
Betulin is known as an anti-inflammatory compound . Extracts of birch bark were tested in actinic keratosis, showing an important therapeutic activity . Birch tree outer bark contains betulin as major compound, but also other pentacyclic triterpens . This composition can produce differences in the biological activity of pure betulin and total bark extract. An important intervention in the inflammatory process can be correlated with the antiproliferative activity. Various anti-inflammatory compounds can diminish tumor incidence and metastases development. This aspect was noticed in different experimental animal models .
In a few hours TPA can induce an inflammatory process by increasing vascular permeability, producing oedema and swelling inside dermis . Both betulin and 1 pp and 3 pp extract determine an intense reduction of oedema. Indometacin is known as a potent anti-inflammatory drug used as reference for the ear oedema model in our research. Dose evaluation regarding indometacin LD50 50 mg/kg in mice is based on a 14-days mortality response. This dosage is correlated with 1.25 mg indometacin/25 mg mouse, just above the topically administered dose. TPA – ear model is useful for the screening of new topical anti-inflammatory compounds and vegetal extracts. TPA topical application determines mass cell infiltration accompanied by the release of mediators which increase vascular permeability and promote neutrophil influx . TPA topical application also causes the production of oxidative stress that can accelerate local injury . Compounds that inhibit COX or LOX enzymes have also shown the inhibition of TPA-ear inflammation  and can be regarded as potent antitumor compounds. Betulin is comparable with indometacin and also the analyzed birch tree extracts in terms of efficacy; however, the extracts reveal the most intense anti-inflammatory potential (Figures 3 and 4), because of the aggregation of effects of other triterpenes, also present in the extract composition, even in small concentrations (betulinic acid , lupeol etc.).
Because of the intense anti-inflammatory activity of 3 pp extract, which shows the highest betulin content, the main conclusion which can be drawn is that betulin is a promising compound in this therapeutic field, in perfect correspondence with other previously reported data . Our work compared betulin to a potent anti-inflammatory agent, indometacin, and the remarkable effects of the pentacyclic triterpene are obvious even after the application of water content evaluation test  depicted in Figure 5; this method allowed us to conclude that the anti-inflammatory activity of birch bark extracts is comparable to the one of indometacin.
All the details about betulin extraction from natural sources and also its mechanism of activity increase the interest in the therapeutic application of this promising pharmacological agent.
New extraction protocol revealing a high betulin content in the outer bark of the birch tree is reported. The extraction products have been extensively characterized using HPLC, NMR, Raman and SERS spectroscopy. Combination between the extraction procedure using solvents and a proper temperature led to a final product with a very high content in active compounds such as betulin. Betulin together with extracts with a high concentration of betulin developped a strong in vitro antiproliferative effect and an important in vivo activity, mainly anti-inflammatory activity, which adds to its potent antitumor properties.
The bark of birch tree (Betula pendula Roth, Betulaceae family) was collected in April 2010 from Ponoarele, Mehedinţi, Romania (Source A) and from Aninei Mountains, Romania (Source B). The plant material was authenticated by the Botanical Department, Faculty of Pharmacy, University of Medicine and Pharmacy, Timisoara, Romania, where the voucher specimens (1120 and 1121) have been deposited. The plant material is grey-white and peels in horizontal stripes.
Extraction of active principles
15 g of birch bark vegetal product (source A and B, see Table 2*) were placed inside a filter paper thimble in a Soxhlet extractor, then extracted with 2-propanol or ethanol (96% v/v) as mentioned in Table 2. The reagents used were commercial products (Reactivul Bucuresti) and used without further purification. Melting points (m.p.) were determined on a Böetius PHMK (Veb Analytik Dresden) instrument. All extracts were standardized and the content in active principles was established.
Preparation of dry extracts
After 6 h of extraction, all the flasks were allowed to cool at room temperature (~25°C) for 24 h. For the 2-propanol extracts from both sources A and B, one can notice the spontaneous formation of crystalline precipitates (1 pp and 3 pp, respectively) which were separated by vacuum filtration and washed with cold distilled water. Each precipitate was then dried in an oven at 90°C for 24 h (m.p = 256–258°C for 1 pp and 255-256°C for 3 pp respectively). After their removal, the resulted solution was concentrated to approx. 80 mL using a rotary evaporator (100 mmHg, 50°C), leading to the separation of cream-colored solids (1 and 3, respectively) by vacuum filtration, washed with cold water and then dried in an oven at 90°C for 24 h.
The ethanolic extracts from both sources A and B were concentrated to approx. 80 mL using a rotaevaporator (100 mmHg, 50°C); the resulted cream-colored solids (2 and 4) were separated by vacuum filtration and washed on with cold water, then dried in a oven at 90°C for 24 h.
The dried extracts were weighed and the yield was calculated based on the wet weight of birch bark. The extraction yield varied from 7 to 10% depending on the extraction solvent, the yield in propanol being higher compared to ethanol.
HPLC coupled with mass spectrometer
HP 1100 Series binary pump, Degasser online 1100 Agilent, auto sampler HP 1100 Series, thermostat HP 1100 Series, mass spectrometer Agilent Ion Trap 1100 SL
HPLC working conditions: Analytical column: Zorbax SB-C18 100 mm x 3.0 mm i.d., 3.5 μm (Agilent), Filter on-line 0.2 microns (Agilent). Mobile phase: isocratic elution using formic acid 0.4% (V/V) / methanol 14/86 (V/V). Flow: 1 ml/min, temperature: 40°C. Injection volume: 2 μl
• Betulin - MS – ion m/z 425.6 monitoring, corresponding to protonated betulin dehydration product [M-H2O]+
• Betulinic acid - MS – ion m/z 439.6 monitoring, corresponding to protonated betulinic acid dehydration product [M-H2O]+
MS working conditions: Ions source: APCI + (atmospheric pressure chemical ionisation). Ionization mode: positive. Electrospray: nitrogen, pressure 60 psi. Vaporiser: 400ºC. Drying gas: nitrogen, debit 7 L/min, temperature 300ºC. Capillary voltage: 2000 V. Analysis mode: SIM-MS, m/z 425.6 (betulin) and 439.6 (betulinic acid)
All chromatographic operations were carried out at ambient temperature.
For quantitative determination betulin / betulinic acid standards were used (Extrasynthese, France, lot 05112416 and lot 05112407, respectively).
10 ± 5 mg powder were weighed in a 10 ml flask and solubilised with a mixture of acetonitril / acetone 50/50. Two dilutions were prepared: 1/1000 for betulin analysis and 1/100 for betulinic acid.
Calibration curve for betulin and betulinic acid were built within the concentration range of 44.2-884 ng/ml and 39.5-790 ng/ml, respectively (Additional file 5: Table S1 and Additional file 6: Table S2, Additional file 7: Figures S5 and Additional file 8: Figure S6). All solutions were prepared in methanol / water 50/50.
The carbon spectra were recorded at 150,86 MHz 13C Larmor frequency with a Bruker AVANCE-600 spectrometer, using the standard CP/MAS pulse sequence . The spinning frequency of the sample was νR = 12 kHz, the applied 1H 90° pulse length was 3.8 μs and the signal was acquired under two-pulse phase-modulated (TPPM) 1H decoupling at 70 kHz by averaging 10.000 scans with a recycle delay of 3 s. The CP transfer was optimized for the first Hartmann – Hahn matching condition (ν1C = ν1H - νR) and a contact pulse of 1.5 ms was used. All the experiments were performed at room temperature. Carbon-13 chemical shifts are expressed in parts per million (ppm) and calibrated with respect to tetramethylsilane.
Raman and SERS spectroscopy
FT-Raman spectra of the extracts have been recorded using a Brucker Equinox 55 spectrometer with an integrated FRA 106 s Raman module fiber optic coupled with the Ramanscope II Raman microscope. The 1064 nm line from a Nd: YAG laser has been employed for Raman excitation and a Ge detector operation at liquid nitrogen temperature for detection.
Additionally, surface enhanced Raman scattering (SERS) has been employed in order to get insight into the adsorption properties of the extract compounds. Citrate reduced Ag colloidal nanoparticles have been employed as SERS substrate. The localised surface plasmon resonance (LSPR) of such nanoparticles exhibits an electronic absorption band at 410 nm. 3.8 mg extract 1 pp has been dissolved in 2 ml ethanol and sonicated for 10 minutes. Upon adding to Ag nanoparticles trace amount (cca 10 ul) of ethanol-extract solution, the Ag colloid changes in colour from grey-yellow to dark, suggesting a complementary aggregation in the presence of the adsorbed species. Consequently, their LSPR shifts to higher wavelength, therefore the 632 nm laser line excitation falls within the resonance condition of the so-called Ag-adsorbate charge transfer band and an enhanced Raman signal of the Ag-betulin complex could be obtained. SERS spectra have been recorded using a DeltaNU Raman spectrometer equipped with a He-Ne laser emitting at 632.8 nm. The laser power was 40 mW and the spectral resolution of 10 cm-1.
Determination of antiproliferative activities
Growth inhibiting effects were measured in vitro on four malignant human cell lines (ECACC, Salisbury, UK): A431 (skin epidermoid carcinoma), A2780 (ovarian carcinoma), HeLa (cervix adenocarcinoma) and MCF7 (breast adenocarcinoma) by means of MTT assay . The cells were maintained in minimal essential medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum, 1% non-essential amino acids and an antibiotic-antimycotic mixture. Briefly, near-confluent cancer cells were seeded onto a 96-well microplate (5000 cells/well) and, after an overnight new medium (200 μL) containing the tested extracts was added. The highest concentration was 30 μg/ml. After incubation for 72 h at 37°C in humidified air containing 5% CO2, the living cells were assayed by the addition of 5 mg/mL MTT solution (20 μL). MTT was converted by intact mitochondrial reductase and precipitated as blue crystals during a 4-h contact period. The medium was then removed and the precipitated formazan crystals were dissolved in DMSO (100 μL) during a 60-min period of shaking at 25°C. Finally, the reduced MTT was assayed at 545 nm, using a microplate reader; wells with untreated cells were utilized as controls. Stock solutions of the tested substances (10 mg/ml) were prepared with DMSO. The highest DMSO content of the medium did not have any significant effect on the cell proliferation.
Animal studies were conducted on C57BL/6 J female mice of 8 weeks old. Mice were purchased from Charles River (Sulzfeld, Germany). The work protocol followed all NIAH-National Institute of Animal Health rules: animals were maintained during the experiment in standard conditions: 12 h light–dark cycle, food and water ad libitum, temperature 24°C, humidity above 55%. All experiments were approved by UMFVBT Bioethical Committee. The number of mice taken into study was twenty four divided in six groups as follows:
• group A : mice on which TPA in acetone was administrated on the ear
• group B: mice on which TPA in acetone was administrated on the ear followed after 30 minutes by indomethacin as control
• group C: mice on which TPA in acetone was administrated on the ear followed after 30 minutes by betulin
• group D: mice on which TPA in acetone was administrated on the ear followed after 30 minutes by 1 pp extract
• group E mice on which TPA in acetone was administrated on the ear followed after 30 minutes by 3 pp extract
• group I: blank (non-treated)
Inflammation was induced in both ears of each mouse by the topical application of 2 μg TPA dissolved in 20 μL of acetone to both the inner and outer ear surfaces. Thirty minutes after the application of TPA, the inner and outer surface of each ear was treated with 2 mg of betulin, or the equivalent quantity of birch tree extract. The same quantity of indomethacin, 2 mg, was used as positive control. The solvent was acetone: DMSO in molar ratio 9:1 and the quantity administrated was 0,1 ml [25, 31]. Mice were killed after 4 h by cervical dislocation and ears were collected. The ears were weighted immediately and considered as wet weight. The ears were dried for 24 h in dry oven, weighted again and the weight defined as dry weight. Skin water content was calculated by subtracting the dry weight from the wet weight and then dividing to wet weight. It is expressed as H2O/mg dry weight .
For the histological analysis, tissue samples (skin) were fixed in 10% formalin solution, embedded in paraffin and cut at 4 microns. Finally, after removal of paraffine, the samples were stained with H&E (hematoxylin-eosin) and microscopically analyzed.
Experiments were carried out in triplicate and statistically analyzed by one-way ANOVA and presented as mean ± SEM; p < 0.01 was considered significant.
Authors ’ contributions
CS, IL and OV carried out the extraction procedures. CS, MA, MM and SCP carried out the physical-chemical analysis of the extracts. CD, AG and IZ carried out the biological tests. All authors participated in the article’s design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Mullauer FB, Kessler JH, Medema JP: Betulin is a potent anti-tumor agent that is enhanced by cholesterol. PLoS ONE. 2009, 4 (4): e1-10.1371/journal.pone.0005361.
Şoica C, Dehelean C, Ordodi V, Antal D, Vlaia V: Complexation with hydroxipropilgamma cyclodextrin of birch tree extract. Physico-chemical characterisation of their binary products. Rev Chim. 2008, 59: 678-681.
Rajendran P, Jaggy M, Singh MK, Mukherjee R, Burman AC: Pharmacological evaluation of C-3 modified betulinic acid derivates with potent anticancer activity. Invest New Drugs. 2008, 26: 25-34. 10.1007/s10637-007-9081-4.
Hänsel R, Keller K, Rimpler H, Schneider G: Drogen A-D: Betula. 1992, Berlin: Springer Verlag
Yogeeswari P, Sriram D: Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem. 2005, 12: 657-666. 10.2174/0929867053202214.
Nosik NN, Deriabin PG, Isaeva EI, Kondrashina NG, Lavrukhina LA, Inozemtsev AN, Presnova GA, Topoleva TV: Interferon-inducing properties of dry birch bark extract and its effect on experimental infection caused by hepatitis C virus. Vopr Virusol. 2005, 50: 29-32.
Alakurtti S, Taru M, Salme K, Jari YK: Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci. 2006, 29: 1-13. 10.1016/j.ejps.2006.04.006.
Chichewicz RH, Kouzi SA: Chemistry, biological activity and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev. 2004, 24: 90-114. 10.1002/med.10053.
Flekhter OB, Medvedeva NI, Karachurina LT, Baltina LA, Galin FZ, Zarudii FS, Tolstikov GA: Synthesis and pharmacological activity of betulin, betulinic acid and allobetulin esters. Pharm Chem J. 2005, 39: 401-404. 10.1007/s11094-005-0167-z.
Kovalenko LP, Shipaeva EV, Balakshin VV, Presnova GA, Chistyakov AN, Klodt PM, Kudrin VS, Durnev AD: Antiallergic activity of birch bark dry extract with at least 70% betulin content. Pharm Chem J. 2009, 43: 110-114. 10.1007/s11094-009-0242-y.
Guidoin MF, Yang J, Pichette A, Roy C: Betulin isolation from birch bark by vacuum and atmospheric sublimation. A thermogravimetric study. Thermochimica Acta. 2003, 398: 153-166. 10.1016/S0040-6031(02)00358-1.
Soica CM, Dehelean CA, Peev CI, Aluas M, Zupko I, Kasa P, Alexa E: Physico-chemical comparison study of betulinic acid, betulin and birch bark extract and in vitro investigation of their cytotoxic effects towards skin epidermoid carcinoma (A431), breast carcinoma (MCF7) and cervix adenocarcinoma (HeLa) cell-lines. Nat Prod Res. 2012, 26: 968-974. 10.1080/14786419.2010.545352.
De Oliveira BH, Santos AM, Espindola DM: Determination of the triterpenoid, betulinic acid, in Doliocarpus schottianus by HPLC. Phytochem Anal. 2002, 13: 95-98. 10.1002/pca.628.
Tolstikova TG, Sorokina IV, Tolstikova TA, Tolstikova AG: Biological activity and pharmacological prospects of lupine terpenoids: natural lupane derivatives. Bioorg Khim. 2006, 32: 42-55.
Chen QH, Fu ML, Liu J, Zhang HF, He GQ, Ruan H: Optimization of ultrasonic-assisted extraction (UAE) of betulin from white birch bark using response surface methodology. Ultrason Sonochem. 2009, 16: 599-604. 10.1016/j.ultsonch.2008.11.009.
Zhang Y-H, Yu T, Wang Y: Extraction of betulin from bark of Betula platyphylla by supercritical carbon dioxide extraction. Journal of Forestry Research. 2003, 14: 202-204. 10.1007/BF02856830.
Diouf PN, Stefanovic T, Boutin Y: The effect of extraction process on polyphenol content, triterpene composition and bioactivity of yellow birch (Betula alleghaniensis Britton) extracts. Industrial Crops and Products. 2009, 30: 297-303. 10.1016/j.indcrop.2009.05.008.
Jager S, Laszczyk MN, Scheffler A: A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betula alba cortex). Molecules. 2008, 13: 3224-3235. 10.3390/molecules13123224.
Eckerman C, Ekman R: Comparison of solvents for extraction and crystallization of betulinol from birch bark waste. Paperi ja Puu. 1985, 67: 100-106.
Dehelean CA, Cîntă Pînzaru S, Peev CI, Soica C, Antal DS: Characterization of birch tree leaves, buds and bark dry extracts with antitumor activity. J Optoelectr Adv Mat. 2007, 9: 783-787.
Falamas A, Cînta Pinzaru S, Dehelean CA, Peev CI, Soica C: Betulin and its natural resource as potential anticancer drug candidate seen by FT-Raman and FT-IR spectroscopy. J Raman Spectrosc. 2011, 42: 97-107. 10.1002/jrs.2658.
Abyshev AZ, Agaev EM, Guseinov AB: Studies of the chemical composition of birch bark extracts (Cortex betula) from the Betulaceae family. Pharm Chem J. 2007, 41: 22-26.
Huyke C, Laszczyk M, Scheffler A, Ernst R, Schempp CM: Treatment of actinic keratoses with birch bark extract, a pilot study. JDDG. 2006, 4: 132-137. 10.1111/j.1610-0387.2006.05906.x.
Durvanei AM, Ribeiro OG, Pizzocaro KF, De Franco M, Cabrera WK, Starobinas N, Gallois V, Siqueira M, Seman M, Ibañez OM: Resistance to melanoma metastases in mice selected for high acute inflammatory response. Carcinogenesis. 2001, 22: 337-342. 10.1093/carcin/22.2.337.
Bralley EE, Greenspan P, Hargrove JL, Wicker L, Hartle DK: Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J Inflamm. 2008, 5: 1-8. 10.1186/1476-9255-5-1.
Al-Reza SM, Yoon JI, Kim HJ, Kim JS, Kang SC: Anti-inflammatory activity of seed essential oil from Zizyphus jujuba. Food Chem Toxicol. 2010, 48: 639-643. 10.1016/j.fct.2009.11.045.
Patocka J: Biologically active pentacyclic triterpenes and their current medicine signification. J Appl Biomed. 2003, 1: 7-12.
Andrew ER: Magic angle spinning. Intern Rev Phys Chem. 1981, 1: 195-224. 10.1080/01442358109353320.
Benett AE, Rienstra CM, Auger M, Lakshmi KV, Griffin RG: Heteronuclear decoupling in rotating solids. J Chem Phys. 1995, 103: 6951-6957. 10.1063/1.470372.
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4.
Yasukawa K, Takido M, Matsumoto T, Takeuchi M, Nakagawa S: Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stage carcinogenesis. Oncology. 1991, 48: 72-76. 10.1159/000226898.
Authors would like to thank for the financial support offered through the project no. POSDRU 89/1.5/S/60189 with the title “Postdoctoral Programs for Sustainable Development in a Knowledge Based Society” and PN_II_ID_2284/2008, Nr. 537 from ANCS, Romania.
The authors declare no conflict of interest.
Electronic supplementary material
Additional file 1: Figure S1. Full-scan spectra of betulin (above) and betulinic acid (below) in the mobile phase. (DOC 26 KB)
Additional file 3: Figure S3. FT-Raman spectra of the 1 pp and 3 pp extracts (c and d, respectively) in comparison with the spectra of betulin (a) or early reported extract (b) (Dehelean et. al, JOAM, 2007 ). Note the relative intensity of the band marked with arrow, showing the impurity presence. Excitation 1064 nm, 350 mW. (DOC 451 KB)
Additional file 4: Figure S4. SERS spectra of the sample 1 (a and b) in comparison with the FT-Raman of the solid 1 pp sample. The solvent (ethanol) spectrum (d) is also given to avoid misinterpretation of the Raman bulk contribution to the overall spectral shape. Excitation: 632.8 nm (a, b, d) and 1064 nm, c). (DOC 273 KB)
About this article
Cite this article
Dehelean, C.A., Şoica, C., Ledeţi, I. et al. Study of the betulin enriched birch bark extracts effects on human carcinoma cells and ear inflammation. Chemistry Central Journal 6, 137 (2012). https://doi.org/10.1186/1752-153X-6-137
- Birch extract
- 13C NMR